Biochemistry · Skim version

Basic Concepts of Enzyme Action

About 2 min to skim · 5 figures · Rewritten on

Read the full lesson → Skim the whole course →

The guiding idea

Can an enzyme make an impossible reaction happen? No — it can only make a possible one fast.

Can an enzyme make an impossible reaction happen?

From the film

  • An enzyme lowers the ridge between substrate and product; it never moves the valleys.
  • Which valley is lower (ΔG) decides which way a reaction runs; the ridge height (ΔG‡) decides how fast.
  • At 25 °C, every 5.7 kJ/mol taken off the barrier makes a reaction ten times faster.
  • An enzyme speeds the forward and backward trips by the same factor, so the equilibrium constant stays the same.
  • It lowers the top by gripping the transition state more tightly than the substrate.
  1. Where a reaction ends up: ΔG, ΔG°′ and Q

  2. How fast it gets there: the height of the hill

    AI-generated illustration: two valleys separated by a mountain ridge. A grey dashed trail crosses the ridge at a high notch; a gold trail crosses the same ridge at a lower notch, with many more travellers on it. An inset shows that the floors of both valleys stay at the same height with or without the enzyme.
    An enzyme opens a lower pass over the same ridge. The valleys, free substrate and free product, stay exactly where they were, so the equilibrium is unchanged; only the height of the crossing, and so the speed, changes. AI-generated illustration
  3. How an enzyme lowers the top: grip the transition state

    AI-generated illustration: the same enzyme active site, shaped like a stretched oval, holds a round substrate loosely with gaps but holds the stretched transition state snugly with many contacts. An inset shows a stable look-alike of the transition state fitting just as snugly without reacting.
    The active site is built for the transition state, not the substrate. The extra grip on the transition state is what lowers the top of the barrier, and a stable look-alike that copies its shape binds more tightly than the real substrate. AI-generated illustration
  4. The evidence: transition-state analogs bind tighter

  5. A separate question: does the active site change shape?

    AI-generated illustration: a three-step induced-fit strip shows a substrate approaching an open enzyme cleft, the cleft's two lips closing around the bound substrate as two catalytic groups line up, and the site reopening as product leaves. One inset shows the lock-and-key model, a rigid pocket cut to the substrate's shape. A second inset shows conformational selection: open and closed forms of the enzyme interconvert, and substrate binds the closed form.
    Does the active site change shape? Lock and key: a rigid site already shaped for the substrate. Induced fit: binding closes the site and lines up catalytic groups. Conformational selection: open and closed shapes interconvert first, and substrate picks the one that fits. Which shape the site fits best, the transition state, is a separate question. AI-generated illustration
  6. Tight binding as a drug strategy

    AI-generated illustration: a statin occupies the substrate-binding pocket of HMG-CoA reductase while HMG-CoA remains outside. A slower shared pathway branches toward cholesterol synthesis and CoQ10 and isoprenoids. A dashed connection to a muscle-cell inset marks proposed lower availability and possible mitochondrial effects as an unproven mechanism.
    Statins competitively inhibit HMG-CoA reductase and slow the shared biosynthetic pathway. Reduced CoQ10 and isoprenoid availability with possible mitochondrial effects is one proposed, unproven explanation for muscle symptoms; true muscle damage with a large CK rise is rare. AI-generated illustration
  7. Naming enzymes and their helpers

    AI-generated illustration: an enzyme with an empty cleft and its cofactor outside is labelled inactive apoenzyme; the same enzyme with the cofactor seated is the active holoenzyme. Below, one inset shows NAD⁺ as a loosely bound coenzyme that binds, reacts and leaves; the other shows FAD locked into the cleft as a tightly bound prosthetic group.
    Apoenzyme (cofactor missing, inactive) and holoenzyme (cofactor bound, active). NAD⁺ and FAD are both coenzymes; what differs is how tightly they bind. NAD⁺ comes and goes, while tightly bound FAD stays put and so counts as a prosthetic group. AI-generated illustration
  8. Going deeper

Read the full lesson → Skim the whole course →